Vascular lesions are divided into two main groups: tumors and vascular malformations 1 . Hemangiomas are the most common vascular endothelial benign tumors of childhood 2 . They are usually not obvious at birth. The prevalence in 1-year-old infants is around 10-12% 3 , and is directly proportional to the age of the application, the size, the visibility and the symptom of the lesion 4 . They are mostly localized on head and neck region 5 .
Rapid growth after birth, stagnation in growth, shrinkage and getting smaller spontaneously are their common clinical course 6 . Superficial endothelial angioblast proliferation responsible for vasculogenesis in proliferative events has been demonstrated 7, 8 . As a result, the imbalance between positive and negative vasculogenic factors is influential in the pathogenesis of hemangioma 9 . Tumors show a rapid growth in the 6-10-month period, and become the largest state around 1-year-old-age. After one year of age, especially after 18 months of age, they tend to shrink due to apoptosis rather than proliferation. Apoptosis is highest among 13-48 months and decreases after 48 months 10, 11 . In contrast, vascular malformations usually do not get smaller. Female predominance, association with low gestational age and prematurity are other clinical features. 12, 13 Increase in size is the major cause of admission.
Although they are usually followed up without treatment, some hemangiomas -owing to size -may require treatment due to impaired vital organ function, hemorrhage and heart failure. Periorbital, ear canal, nasopharynx, subglottic region are critical localizations of them, and some of them have to take treatment. In this article, clinical and therapeutic features of hemangiomas in children were evaluated.
Material and Methods
This is a single center, retrospective study. Files of 49 patients with hemangioma who were referred to Department of Pediatric Oncology were evaluated. Ethics Committee approval was obtained from Gülhane Military Medical Academy Local Ethics Committee (03.02.2015-7). SPSS 15.0 was used in the analysis of the data. The median, mean, minimum and maximum for continuous variables, percent and number values for discrete variables, and Spearman or Pearson test for correlation were used. Age, sex, place of residence, number of hemangiomas, treatment modality, age of application, presence of birth, and laterality (right-left-midline) for assessment of treatment response were evaluated as possible predictors. Treatment indications for hemangioma were compression to vital organs, cosmetic reasons, complications of critical organ localization such as periorbital, ear canal, nasopharynx, and subglottic region, Kasabach-Meritt syndrome, ulceration and bleeding of hemangioma, and giant hemangioma of liver because of heart failure. Response criteria to treatment were the followings: 1) stop growing, 2) shrinkage or flattening of the lesion, 3) fading of surface color. It was accepted that the lesion in which both of the three criteria were observed had good response, partial response in the lesion in which one of the three criteria was observed, and lack of response in lesions where there was no improvement. Parameters identified with univariate logistic regression analysis was further entered into multivariate analysis, with backward selection, to determine independent predictors of survival. A 5% type-I error level was used to infer statistical significant.
Results
The demographic features of 49 children with hemangiomas were summarized in Table  I . Growth (100%) and bleeding (8.1%) of hemangioma were the main clinical problem to apply to hospital. The largest hemangioma was 60x75 mm with Kasabach-Meritt syndrome, which was the most dangerous complication. There were 5 (10.2%) hemangiomas related to the eye as a specific site. Median (range) values of white blood cell, hemoglobin, platelets, activated partial thromboplastin time (aPTT), prothrombin time (PT), international normalized ratio (INR) were 9.9x10 3 /mm 3 (1.6-16.5), 11.7 g/L (9.4-17.4), 340x10 3 / mm 3 (61-827), 29.6 sec (20.7-40.5), 11.6 sec (10.5-16.8), and 1 (0.7-1.2), respectively; D-dimer level in a patient with KasabachMeritt syndrome was >5000 ng/ml (0-175).
Abdominal ultrasonography was performed in 34 patients, and it revealed a hepatic hemangioma in 1 case (3%). Computerized tomography (CT) and MRI were used in 2 (4.1%) cases with respiratory distress (one with Kasabach-Meritt syndrome); hemangiomas were detected in the glottic area.
Spontaneous regression was observed in 65% of our cases and the median time of onset of regression was 19 months. Lip hemangiomas in 2 cases of our series did not show regression. There were five periorbital cases. Four of these were treated. Very good response to propranolol treatment was observed. Intralesional steroids were not administered.
In the patient with Kasabach-Meritt, hemangioma did not respond to treatment with methylprednisolone, vincristine, interferonalpha and propranolol, the coagulation parameters could be corrected by embolization. The coagulation parameters quickly improved and no additional transfusions were required. No progression was detected and no additional drug was used. The patient was followed up to one year of age and the lesion was evaluated as 7 mm in USG.
Only one patient received surgical treatment. There was a strong negative (r=-0.913, p <0.001) correlation between presence of lesion at birth and age of admission, and moderate negative (r=-0.37, p=0.013) correlation between gender and size of lesion. In univariate analysis, the number of hemangiomas more than 1 (p=0.026, OR = 9.5, 95% CI 1.3-69.2) and undergone to other treatment modalities other than observation (p=0.008, OR=10.5, 95% CI 1.8-59.1) were found to be possible predictors for the clinical response of hemangioma. In the multivariate analysis, treatment other than observation was an independent predictor of clinical response (p=0.014, OR=9.8, 95% CI 1.5-90.9) (Table II) .
Discussion
Rate of hemangiomas in terms ranges from 1 to 4%, but this rate increase to 22% in preterms 13 . Prematurity rate was 6.1% in this study. In general, 20% of the cases have lesions at birth; this rate was 59.2% in our series.
Median admission time of cases was 7 months, and was consistent with a proliferative phase of hemangioma. To be so small to be noticed at birth, late recognition by family, and Parallel to the fact that only the hemangiomas adjacent to the lips do not usually regress because of being fed directly from the labial artery, lip hemangiomas in 2 cases of our series did not show regression 13 .
Fifty to 60% of hemangiomas are localized to the head and neck region, while 25% are located in the body and 15% in the extremities 5 . Sen et al. 14 reported localization of hemangioma as 70% on the head and neck region in their study. In our cases, hemangiomas were 67.4% in the head and neck region, 16.3% in the trunk and 16.3% in the extremity region, and these were consistent with the literature.
As the lesion size increases, the complication rate increases 11 times; hemorrhage, ulceration, infection and compression findings are some of these complications, the most common complication is ulcerations 10 .
One of the regions where lesion size is important is periorbital hemangiomas 15, 16 . Periorbital hemangiomas can cause permanent blindness by compressing the eyeball within as short as 2 weeks 15, 16 . Therefore, lesion size in the hemangiomas of periorbital region has a special precaution. Orbital hemangiomas are classified as <1 cm in Group 1,> 1 cm in Group 2, and unmeasured diffuse eyelid hemangiomas in Group 3. Group 4 is defined for patients with PHACE (posterior fossa malformations, hemangiomas, arterial anomalies, aortic coarctation, cardiac anomalies, midline developmental disorders and congenital cataracts, microphthalmia, optic ner ve hypoplasia) 17 .
Hemangiomas usually do not require treatment, but compression to vital organs, cosmetic reasons and complications may require treatment. The cases of hemangiomatosis may require further examination in terms of visceral organ involvement 18 . Having ≥5 hemangiomas is called hemangiomatosis, and the condition to be noted in these patients is the more visceral organ involvement than the classical hemangioma patients. Since it is the most commonly involved intraabdominal organ, abdominal ultrasonography (USG) should be planned to assess liver involvement 18 . These organ involvements can lead to lifethreatening complications, especially in the first months of life, and have prognostic significance in terms of treatment approach 18 .
Hemangiomas were detected only in 1 (3%) of the 34 patients who had undergone abdominal USG abdominal incidentally, in which case there was no cutaneous hemangioma. When we reviewed the literature, this ratio varied between 10-22% 18, 19 .
Kasabach-Meritt syndrome accompanied by thrombocytopenia, hemolytic anemia and consumption coagulopathy was defined in capillary hemangiomas in 1940. This consumption coagulopathy is due to endothelial dysfunction in the hemangioma 20 . We had first planned to start propranolol for the patient Kasabach-Meritt syndrome, but due to progressive clinic, methylprednisolone, vincristine, interferon-alpha therapies which has been successfully used in Kasabach-Meritt treatment 21 , were decided to start. Intra-arterial embolization was performed because of the CI: confidence intervals; OR: Odds ratio was estimated using logistic regression model. Simple: first was selected to evaluate the effect of categorical predictors.
Volume 59 • Number 3
Children with Hemangioma lack of adequate and rapid response to these treatments and the high risk of bleeding. In this patient, propranolol therapy could be started alone or in addition to this treatment 22 .
In the diagnosis of hemangiomas, USG, MRI, endoscopic imaging methods and computed tomography can be used. Abdominal USG was used to scan the liver hemangioma. Tomography and MRI were usually not used. After oral propranolol was started, the complaints decreased. Deep resident hemangioma with cutaneous presentation could only be detected by MRI after USG.
Hemangiomas with critical organ localization may require treatment, because they will lead to complications. Periorbital in terms of visual impairment, ear canal in terms of hearing, nasopharynx, and subglottic region in terms of respiratory distress are these critical localizations. Haggstrom et al. 10 have reported that important criteria for initiation of treatment are size and location of the lesions, especially on face. Treatment modalities for hemangiomas can be roughly divided into two categories, systemic and local. Glucocorticoids and propranolol are the first preferred agents 23, 24 . Oksiuta et al. 22 reported that oral propranolol therapy showed excellent efficacy in 87% of patients, and that severe tachycardia was observed in only one patient. They also suggested that the dose of propranolol could be increased to 3 mg/kg and that topical treatment may be an alternative treatment in cases who oral treatment can not be tolerated 22 . Kovacevic et al. 25 showed excellent response to topical treatment containing 1% propranolol in 62.5% of patients with superficial infantile hemangioma. All patients had regression after lesions after treatment. According to randomized controlled trials and meta-analyses, efficacy was found in the range of 96-98% at 6 months of use of propranolol at a dose of 2-3 mg/kg/day, and severe side effects were found [26] [27] [28] [29] . The most common side effects have been reported as bronchitis, sleep disturbances, diarrhea and vomiting at rates of 10% or more 26 . Vincristine and interferon alpha can be used as second choice in unresponsive cases 30, 31 . Topical treatments can be used in small, superficial hemangiomas without life threatening. These treatments consist of agents such as intralesional steroids, topical steroids, imiquimode, and topical timolol [32] [33] [34] [35] . Surgery in hemangiomas of periorbital region with cosmetic and organ dysfunction in selected cases, laser in cutaneous hemangiomas with a depth of not less than 1.2 mm, embolization in liver involvement and Kasabach-Meritt syndrome are the other treatment methods that can be applied [36] [37] [38] .
Oral propranolol or steroids are the first choice in glottic hemangiomas and laser ablation methods are used in unresponsive cases 39, 40 . In cases with unexplained upper respiratory obstruction findings, hemangiomas should be considered in the differential diagnosis. Approximately 35% of our patients were treated: 64% of the cases responded to treatment; treatment response rates were compatible with the literature. The efficacy of oral propranolol therapy and oral steroid treatments varies between 60% and 84% 23, 41 . Only one patient received surgical treatment. Other patients were treated with propranolol and/or oral steroids. The lesions of the treated patients were mostly localized to the head and neck region. Concentration of the lesions of the patients in the head and neck region causes an increase in treatment rates. This can be attributed to the placement of important organs and cosmetics in the head and neck region. Intracranial, shoulder (Kasabach-Meritt), tongue, lip, subglottic, eyelid and orbital were the critical regions where we treated.
In conclusion, hemangiomas grow very rapidly in the first year of life, although they are very small at birth. Ulcers, infections, hemorrhages and special places such as larynxes, tongue, eyelids, ear canal are the treatment indications. Treatment modalities include observation, medical treatment options such as steroid, propranolol, interferon, chemotherapy, interventional radiologic lesion embolization, surgical resection and laser. In our study, the number of hemangiomas and treatment modalities out of observation were found to be effective in the hemangioma course.
